Warning: The NCBI web site requires JavaScript to function. more...
Department of Medicine, Cook County Hospital, Hektoen Building, Room 817, Chicago, IL 60612, USA.
In patients infected with human immunodeficiency virus (HIV), zidovudine has been known to cause a severe hypoproliferative anemia that resolves promptly when the drug is stopped. Some patients, however, may come to medical attention after having stopped taking the drug for 1-2 weeks and may already be in the recovery phase and present with severe anemia, normoblastemia, and reticulocytosis. These features can be mistaken for hemolytic disease, as shown by our experience with three such patients.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on